EE03107B1 - Ravimpreparaat ja meetod selle valmistamiseks - Google Patents

Ravimpreparaat ja meetod selle valmistamiseks

Info

Publication number: EE03107B1
Authority: EE; Estonia
Prior art keywords: preparation; pharmaceutical; prepn; clodronate; dissolves
Prior art date: 1992-04-24

Application number

EE9400134A

Other languages

English (en)

Estonian (et)

Inventor

Posti Juhani

Katila Kirsti

Rantala Pertti

Original Assignee

Leiras Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-24

Filing date

1994-11-15

Publication date

1998-08-17

1994-11-15 Application filed by Leiras Oy filed Critical Leiras Oy

1998-08-17 Publication of EE03107B1 publication Critical patent/EE03107B1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EE9400134A 1992-04-24 1994-11-15 Ravimpreparaat ja meetod selle valmistamiseks EE03107B1 (et)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9201299A SE501389C2 (sv)	1992-04-24	1992-04-24	Farmaceutiskt preparat och förfarande för dess framställning

Publications (1)

Publication Number	Publication Date
EE03107B1 true EE03107B1 (et)	1998-08-17

Family

ID=20386054

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9400134A EE03107B1 (et)	1992-04-24	1994-11-15	Ravimpreparaat ja meetod selle valmistamiseks

Country Status (21)

Country	Link
US (1)	US5525354A (fi)
EP (1)	EP0637236B1 (fi)
JP (1)	JP3536106B2 (fi)
AT (1)	ATE143802T1 (fi)
AU (1)	AU671830B2 (fi)
CA (1)	CA2134196C (fi)
CZ (1)	CZ282871B6 (fi)
DE (2)	DE69305335T2 (fi)
DK (1)	DK0637236T3 (fi)
EE (1)	EE03107B1 (fi)
ES (1)	ES2094539T3 (fi)
FI (1)	FI110667B (fi)
GR (1)	GR3022249T3 (fi)
HK (1)	HK13097A (fi)
HU (1)	HU219342B (fi)
IL (1)	IL105403A (fi)
NO (1)	NO306654B1 (fi)
RU (1)	RU2116074C1 (fi)
SE (1)	SE501389C2 (fi)
TW (1)	TW273515B (fi)
WO (1)	WO1993021907A1 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6406714B1 (en)	1992-12-02	2002-06-18	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids
ES2065313T5 (es) *	1993-05-15	2004-01-01	Roche Diagnostics Gmbh	Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.
US5431920A (en) *	1993-09-21	1995-07-11	Merck Frosst, Canada, Inc.	Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) *	1993-11-12	1995-11-27	Leiras Oy	Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en)	1998-06-18	2001-07-12	Merck & Co., Inc.	Wet granulation formulation for bisphosphonic acids
TW390813B (en) *	1994-04-29	2000-05-21	Merck & Co Inc	Wet granulation formulation for bisphosphonic acids
FI98343C (fi) *	1995-03-21	1997-06-10	Orion Yhtymae Oy	Peroraalinen formulaatio
DE19719680A1 (de)	1997-05-09	1998-11-19	Boehringer Mannheim Gmbh	Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) *	1997-11-14	1999-05-25	Nikken Chem Co Ltd	口腔内速溶性固形物及びその製造方法
EP0998932A1 (de) *	1998-10-09	2000-05-10	Boehringer Mannheim Gmbh	Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) *	1998-10-09	2000-05-10	Boehringer Mannheim Gmbh	Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
ES2301477T3 (es) *	1999-02-22	2008-07-01	Merrion Research I Limited	Forma de dosificacion oral solida que contiene un potenciador.
US7658938B2 (en)	1999-02-22	2010-02-09	Merrion Reasearch III Limited	Solid oral dosage form containing an enhancer
SE9901272D0 (sv) *	1999-04-09	1999-04-09	Astra Ab	New improved formulation
PE20011061A1 (es)	2000-02-01	2001-11-20	Procter & Gamble	Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es)	2000-02-01	2001-11-21	Procter & Gamble	Proceso para fabricar bisfosfonatos geminales
CA2446619C (en)	2001-05-11	2011-04-26	Elan Corporation, Plc	Permeation enhancers
US20030070584A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
AU4061702A (en) *	2001-05-15	2003-04-03	Mcneil-Ppc, Inc.	Dip coating compositions containing starch or dextrin
US8309118B2 (en) *	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
US7429619B2 (en) *	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
US7862552B2 (en) *	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
KR101191322B1 (ko)	2006-04-07	2012-10-16	메리온 리서치 Ⅲ 리미티드	증진제를 함유하는 고형 경구용 투여 제형
CA2723558A1 (en)	2008-05-07	2009-11-12	Merrion Research Iii Limited	Compositions of gnrh related compounds and processes of preparation
DE102008022520A1 (de) *	2008-05-07	2009-11-12	Bayer Animal Health Gmbh	Feste Arzneimittelformulierung mit verzögerter Freisetzung
US9089484B2 (en)	2010-03-26	2015-07-28	Merrion Research Iii Limited	Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
US8802114B2 (en)	2011-01-07	2014-08-12	Merrion Research Iii Limited	Pharmaceutical compositions of iron for oral administration
WO2016120378A1 (en)	2015-01-29	2016-08-04	Novo Nordisk A/S	Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57171428A (en) *	1981-04-13	1982-10-22	Sankyo Co Ltd	Preparation of coated solid preparation
DE3767998D1 (de) *	1986-12-20	1991-03-14	Boehringer Mannheim Gmbh	Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
JP2782691B2 (ja) *	1987-09-29	1998-08-06	ワーナー−ランバート・コンパニー	腸溶製剤の安定化
FR2629716B1 (fr) *	1988-04-07	1991-07-19	Sanofi Sa	Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

1992
- 1992-04-24 SE SE9201299A patent/SE501389C2/sv not_active IP Right Cessation
1993
- 1993-04-13 TW TW082102782A patent/TW273515B/zh active
- 1993-04-15 IL IL105403A patent/IL105403A/en not_active IP Right Cessation
- 1993-04-21 DE DE69305335T patent/DE69305335T2/de not_active Expired - Fee Related
- 1993-04-21 HU HU9403067A patent/HU219342B/hu not_active IP Right Cessation
- 1993-04-21 CA CA002134196A patent/CA2134196C/en not_active Expired - Fee Related
- 1993-04-21 RU RU94045950A patent/RU2116074C1/ru not_active IP Right Cessation
- 1993-04-21 DK DK93908973.6T patent/DK0637236T3/da active
- 1993-04-21 AT AT93908973T patent/ATE143802T1/de not_active IP Right Cessation
- 1993-04-21 CZ CZ942614A patent/CZ282871B6/cs not_active IP Right Cessation
- 1993-04-21 ES ES93908973T patent/ES2094539T3/es not_active Expired - Lifetime
- 1993-04-21 US US08/318,650 patent/US5525354A/en not_active Expired - Lifetime
- 1993-04-21 DE DE0637236T patent/DE637236T1/de active Pending
- 1993-04-21 JP JP51895893A patent/JP3536106B2/ja not_active Expired - Fee Related
- 1993-04-21 WO PCT/FI1993/000166 patent/WO1993021907A1/en active IP Right Grant
- 1993-04-21 AU AU39550/93A patent/AU671830B2/en not_active Ceased
- 1993-04-21 EP EP93908973A patent/EP0637236B1/en not_active Expired - Lifetime
1994
- 1994-10-21 NO NO944001A patent/NO306654B1/no unknown
- 1994-10-21 FI FI944961A patent/FI110667B/fi active
- 1994-11-15 EE EE9400134A patent/EE03107B1/xx not_active IP Right Cessation
1997
- 1997-01-09 GR GR970400013T patent/GR3022249T3/el unknown
- 1997-02-05 HK HK13097A patent/HK13097A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0637236A1 (en)	1995-02-08
US5525354A (en)	1996-06-11
CZ282871B6 (cs)	1997-11-12
HK13097A (en)	1997-02-14
DE69305335D1 (de)	1996-11-14
NO944001D0 (no)	1994-10-21
IL105403A (en)	1998-03-10
TW273515B (fi)	1996-04-01
GR3022249T3 (en)	1997-04-30
FI944961L (fi)	1994-10-21
DK0637236T3 (da)	1997-03-17
CZ261494A3 (en)	1995-02-15
FI110667B (fi)	2003-03-14
ATE143802T1 (de)	1996-10-15
ES2094539T3 (es)	1997-01-16
IL105403A0 (en)	1993-08-18
DE637236T1 (de)	1995-07-06
NO944001L (no)	1994-10-21
SE501389C2 (sv)	1995-01-30
EP0637236B1 (en)	1996-10-09
SE9201299L (sv)	1993-10-25
WO1993021907A1 (en)	1993-11-11
HU9403067D0 (en)	1994-12-28
JPH07505898A (ja)	1995-06-29
FI944961A0 (fi)	1994-10-21
RU2116074C1 (ru)	1998-07-27
JP3536106B2 (ja)	2004-06-07
AU671830B2 (en)	1996-09-12
CA2134196A1 (en)	1993-11-11
HU219342B (en)	2001-03-28
SE9201299D0 (sv)	1992-04-24
NO306654B1 (no)	1999-12-06
DE69305335T2 (de)	1997-04-30
CA2134196C (en)	2004-02-10
HUT74572A (en)	1997-01-28
AU3955093A (en)	1993-11-29
RU94045950A (ru)	1996-11-10

Publication	Publication Date	Title
EE03107B1 (et)	1998-08-17	Ravimpreparaat ja meetod selle valmistamiseks
SE9202250D0 (sv)	1992-07-29	Controlled release morphine preparation
ES2144077T3 (es)	2000-06-01	Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
FI973522A0 (fi)	1997-08-27	Vesipitoisia, lesitiinipohjaisia irrotteita ja menetelmät niiden käyttämiseksi
DK0431877T3 (da)	1995-04-03	Cimetidinholdige farmaceutiske midler
FI960851A0 (fi)	1996-02-23	Menetelmä N-amino-1-hydroksi-alkylideeni-1,1-bisfosfonihappojen valmistamiseksi
BR9912066A (pt)	2001-04-10	Uso de um ingrediente ativo; método de tratamento de restenose; e; composição farmacêutica
CA2125662A1 (en)	1993-07-08	Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
ATE285754T1 (de)	2005-01-15	Pharmazeutische zusammensetzung mit lyophilisierten lyposomen welche einen unlöslichen aktiven wirkstoff einschliessen, verfahren zu dessen herstellung
ATE321538T1 (de)	2006-04-15	Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
SE9700885D0 (sv)	1997-03-12	New pharmaceutical formulation
IT1285079B1 (it)	1998-06-03	Sistema attuatore per la compensazione dell'allineamento di una macchina.
NO944405L (no)	1994-11-24	Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse
GR930100090A (el)	1993-11-30	Μέ?οδος για την παραγωγή αλάτων κλαβουλανικού οξέος.
YU48915B (sh)	2002-11-15	Sulfonilkarbamid i postupak za njegovo dobijanje
MX9709453A (es)	1998-02-28	Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
MX9200225A (es)	1992-07-01	Formulacion para verter destinada a la aplicacion de anthelminticos.
EP0824341A4 (en)	1999-07-07	PREVENTING TOOTH LOSS THROUGH ADMINISTRATION OF ALENDRONATE OR ITS SALTS
CA2057456A1 (en)	1992-07-05	Anti depression pharmaceutical
ITPN920071A0 (it)	1992-09-24	Sistema di bloccaggio dell'orientamento a 360° del moncone preangolato per implantologia orale.
IS1881B (is)	2003-08-15	2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi
ATE105494T1 (de)	1994-05-15	Verschlusskoerpr zur verabreichung einer physiologisch aktiven substanz.
FI972453L (fi)	1998-12-11	Menetelmä alasuojana käytettävän vaipan kunnon toteamiseksi

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2010-08-16	MM4A	Lapsed by not paying the annual fees	Effective date: 20091115